Skip to product information

Harvard 3rd Annual Update in Neuro-Oncology 2023

Harvard 3rd Annual Update in Neuro-Oncology 2023

Regular price $30.00 USD
Regular price $30.00 USD Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
Harvard 3rd Annual Update in Neuro-Oncology 2023

Harvard 3rd Annual Update in Neuro-Oncology 2023

Regular price $30.00
Regular price $30.00 Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
    View full details

    Harvard 3rd Annual Update in Neuro-Oncology 2023

    Include: 39 videos + 32 pdfs, size: 12.05 GB
    Target Audience: neurologists, oncologists, neurosurgeons, radiation oncologists, pathologists
     Information:

    Neuro-oncology is a rapidly evolving multi-disciplinary field, which involves the medical, radiation and surgical management of pediatric and adult patients with primary and metastatic tumors of the central nervous system (CNS) and peripheral nervous system (PNS). In addition, modern molecular neuropathology and neuroradiology concepts are essential for accurate diagnosis and classification. This three-day course, Annual Update in Neuro-Oncology, is designed to provide an international audience with a comprehensive review of the diagnosis and management of pediatric and adult patients with primary and metastatic CNS and PNS tumors and neurological complications of cancer.

    Our target audience will be the providers involved in the care of adult and pediatric neuro-oncology patients (oncologists, radiation oncologists, neurosurgeons, neurologists, neuroradiologists and neuropathologists). The course will also be of high relevance to nurse practitioners, physician assistants, psychologists, pharmacists and nurses.

    Who Should Attend

    • Specialty Physicians
    • Nurses, Pharmacists
    • Physician Assistants
    • Psychologists

    Learning Objectives


    Upon completion of this activity, participants will be able to:
    • Identify the role of biomarkers in the diagnosis of pediatric and adult CNS and PNS tumors.
    • Identify standard and novel treatment approaches to pediatric and adult CNS and PNS tumors.
    • Recognize and address neurological complications associated with new cancer therapies.
    • Identify and manage long-term complications of CNS and PNS tumors and their treatment.

    🧠 The Harvard 3rd Annual Update in Neuro-Oncology 2023 is best for neurologists, oncologists, neurosurgeons, radiation oncologists, pathologists, and other healthcare professionals involved in the care of patients with central and peripheral nervous system tumors. It’s ideal for:

    👩‍⚕️ Who Should Attend

    • Clinicians treating primary and metastatic brain and spine tumors
    • Specialists managing neurological complications of cancer
    • Researchers and educators seeking updates on molecular neuropathology and neuroradiology

    📅 Dates: July 26–28, 2023

     

     Topics:

    Wednesday, July 26, 2023

    10:00-10:10 AM Welcome: Pediatric Neuro-Oncology Session Mariella Filbin, MD, PhD
    10:10-10:40 AM Keynote: CAR T Cell Therapy for Diffuse Midline Gliomas Michelle Monje,  MD, PhD
    10:40-11:10 AM WHO Classification, Pediatric CNS Tumors Sanda Alexandrescu, MD
    11:10-11:40 AM Embryonal Tumors Scott Pomeroy, MD, PhD
    11:40 AM-12:00 PM Break
    12:00-12:30 PM Pediatric Low-Grade Gliomas Susan Chi, MD
    12:30-1:00 PM Pediatric High-Grade Gliomas Mariella Filbin, MD, PhD
    1:00-1:30 PM Ependymomas and Glioneuronal Tumors Pratiti (Mimi) Bandopadhayay, MBBS, PhD
    1:30-1:45 PM Live Question & Answer Session Mariella Filbin, MD, PhD
    1:45-2:00 PM Break
    2:00-2:15 PM Choroid Plexus Tumors Viviana Benitez, MD
    2:15-2:30 PM Pineal Tumors Shannon MacDonald, MD
    2:30-2:45 PM Germ Cell Tumors Aaron Yeo, MD
    2:45-3:15 PM Neurofibromatosis Scott Plotkin, MD, PhD
    3:15-3:30 PM Von Hippel Lindau Othon Iliopoulos, MD, PhD
    3:30-3:45 PM Live Question & Answer Session Mariella Filbin, MD, PhD
    3:45-3:50 PM Adjourn Mariella Filbin, MD, PhD

    Thursday, July 27, 2023

    10:00-10:05 AM Welcome: Adult Neuro-Oncology Tracy Batchelor, MD
    10:05-10:30 AM Keynote: Surgical Immunotherapy Clinical Trials for Glioblastoma Multiforme (GBM) E. Antonio Chiocca, MD,PhD
    10:30-10:45 AM Advances in Surgery for Brain Tumors William Curry, MD
    10:45-11:00 AM Advances in Imaging for Brain Tumors Tina Young Poussaint, MD
    11:00-11:15 AM Advances in Radiation for Brain Tumors Helen Shih, MD
    11:15-11:25 AM Live Question and Answer Session Tracy Batchelor, MD
    11:25-11:30 AM Break
    11:30 AM-12:00 PM WHO Classification for Adult Gliomas David Louis, MD
    12:00-12:30 PM Gliomas, IDH-Mutant ​​​​​Nicolas Gonzalez Castro, MD, PhD
    12:30-12:45 PM Gliomas, IDH-Wildtype Isabel Arrillaga,  MD, PhD
    12:45-1:10 PM Advances in Experimental Therapies for Gliomas David Reardon, MD
    1:10-1:30 PM Break
    1:30-1:45 PM Meningioma Wenya Linda Bi, MD, PhD
    1:45-2:00 PM CNS Lymphomas Lakshmi Nayak, MD
    2:00-2:15 PM Pituitary Tumors Pamela Jones, MD
    2:15-2:45 PM Live Question & Answer Session Tracy Batchelor, MD
    2:45-2:50 PM Adjourn

    Friday, July 28, 2023

    10:00-10:05 AM Welcome: Neurological Complications of Cancer Patrick Wen, MD
    10:05-10:30 AM Keynote: Neural Regulation of Cancer Humsa Venkatesh, PhD
    10:30-11:00 AM Metastases to the Brain Priscilla Brastianos, MD
    11:00-11:15 AM Metastases to the Leptomeninges Ricky McFaline-Figueroa, MD, PhD
    11:15-11:30 AM Metastases to the Epidural Space and Spinal Cord John Chi, MD, MPH
    11:30-11:45 AM Live Question and Answer Session Patrick Wen, MD
    11:45 AM-12:15 PM Break
    12:15-12:30 PM Paraneoplastic Neurological Syndromes Eudocia Lee, MD, MPH
    12:30-1:00 PM Common Neurological Complications in Cancer Patients Ugonma Chukwueke, MD, MPH
    1:00-1:15 PM Neurological Complications of Cancer Immunotherapies Jorg Dietrich, MD, PhD
    1:15-1:30 PM Managing Long-Term Survivors of CNS Tumors Deborah Forst, MD
    1:30 – 1:45 PM Live Question and Answer Session Patrick Wen, MD
    1:45-2:00 PM Closing & Adjourn Tracy Batchelor, MD, MPH